Chinese Journal of Pharmacovigilance ›› 2014, Vol. 11 ›› Issue (2): 117-120.

Previous Articles     Next Articles

Recognition and Analysis of Isoniazid Risk

ZHONG Lei, ZHANG Jun, JIAO Li-gong   

  1. Beijing Center for ADR Monitoring, Beijing100024, China
  • Received:2013-07-15 Revised:2016-02-03 Online:2014-02-08 Published:2016-02-03

Abstract: Isoniazid is a commonly used drug in clinic for antituberculosis. The adverse reactions of isoniazid have diverse clinical manifestations accompanied with multiple organ injury. The adverse reactions could increase with combination of some drugs. The drug instruction and related references of isoniazid were summarized to recognize and analyze the risk of isoniazid. Several suggestions were put forward for clinical medication.

Key words: isoniazid, adverse reactions, risk recognition, risk analysis

CLC Number: